Monday, Dec 8, 2025 · SEC filings
What the smart money revealed on Dec 8
523 insider filings came in. We hid 70 planned (10b5-1) sellers and 284 people whose filings were routine, like grants and tax withholding.
5 insiders at Bankwell Financial Group (BWFG) bought $105K of stock
Roles: Director. Several insiders buying in the same few days is rare.
Crescent Biopharma (CBIO) Director Peter Harwin bought $18.2M
1.36M shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
New America Acquisition I (NWAX) CEO Kevin McGurn bought $6M
600,000 shares on the open market. Not a grant or an option exercise.
XOMA Royalty (XOMA) CEO Owen Hughes bought $2.5M
100,000 shares on the open market. Not a grant or an option exercise.
Linde (LIN) CEO Sanjiv Lamba bought $1M
2,520 shares on the open market. Not a grant or an option exercise.
Diamondback Energy (FANG) Director Charles Meloy sold $52.4M
Not marked as a planned 10b5-1 sale. Sold 27% of the shares they held directly. Still holds 1.04M shares.
Eos Energy Enterprises (EOSE) Director Russell Stidolph sold $11.5M
Not marked as a planned 10b5-1 sale. Sold 68% of the shares they held directly. Still holds 364,355 shares.
Eos Energy Enterprises (EOSE) Director Jeffrey Bornstein sold $613K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 50 more real buys
Show 75 more real sales
13F season
Holdings as of Sep 30, 2025 were due Nov 14
81 funds have filed. 74 filed for the quarter before.
Biggest real insider buys, Dec 2–8
Open-market buys by officers and directors, filed in the 7 days up to Dec 8.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.